Correction to “Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia”

Abstract

Nabbouh AI, Hleihel RS, Saliba JL, et al. Imidazoquinoxaline derivative EAPB0503: a promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia. Cancer. 2017;123(9):1662-1673. doi:10.1002/cncr.30515

In the published article, the GAPDH blots for the KG-1α and MOLM13 extracts in Figure 2E were inaccurately presented due to inadvertent errors during figure preparation. The correct Figure 2 is provided below.

Figure 2. Corrected.

The legend for Figure 2 has also been updated (changes in bold) to clarify that the same GAPDH blots for the OCI-AML3 extracts were used in Figures 2E and 2G:

Furthermore, the loading controls for the KG-1α and MOLM13 extracts in Figure 3A were inaccurately labelled as “Actin” instead of “GAPDH”. The correct Figure 3 is provided below.

Figure 3. Corrected.

The authors apologize for these errors and for the inconvenience they may have caused.